Key result
SERCA inhibition with 10 µM cyclopiazonic acid significantly prolonged SR Ca2+ reuptake time from 70.8 ms to 271.3 ms and exacerbated pacing-induced SR Ca2+ and APD alternans magnitude.
Why the study?
The relationship between reduced SERCA function and sarcoplasmic reticulum Ca2+ alternans was not well understood.
Does SERCA inhibition with cyclopiazonic acid exacerbate pacing-induced SR Ca2+ and APD alternans in isolated rabbit hearts?
Does SERCA inhibition with cyclopiazonic acid exacerbate pacing-induced SR Ca2+ and APD alternans in isolated rabbit hearts?
SERCA inhibition exacerbates pacing-induced SR Ca2+ and APD alternans, but SR Ca2+ release alternans always precedes load alternans, indicating RyR refractoriness governs alternans onset even with reduced SERCA function.
Answers are grounded in this paper and cite their sources.
SERCA inhibition amplifies SR Ca2+ and APD alternans in rabbit hearts; extends RyR refractoriness mechanism but leaves open its role in human HF arrhythmias.
Sarcoplasmic reticulum (SR) Ca2+ cycling is tightly regulated by ryanodine receptor (RyR) Ca2+ release and sarco-endoplasmic reticulum Ca2+-ATPase (SERCA) Ca2+ uptake during each excitation–contraction coupling cycle. We previously showed that RyR refractoriness plays a key role in the onset of SR Ca2+ alternans in the intact rabbit heart, which contributes to arrhythmogenic action potential duration (APD) alternans. Recent studies have also implicated impaired SERCA function, a key feature of heart failure, in cardiac alternans and arrhythmias. However, the relationship between reduced SERCA function and SR Ca2+ alternans is not well understood. Simultaneous optical mapping of transmembrane potential (Vm) and SR Ca2+ was performed in isolated rabbit hearts (n = 10) using the voltage-sensitive dye RH237 and the low-affinity Ca2+ indicator Fluo-5N-AM. Alternans was induced by rapid ventricular pacing. SERCA was inhibited with cyclopiazonic acid (CPA; 1–10 μM). SERCA inhibition (1, 5, and 10 μM of CPA) resulted in dose-dependent slowing of SR Ca2+ reuptake, with the time constant (tau) increasing from 70.8 ± 3.5 ms at baseline to 85.5 ± 6.6, 129.9 ± 20.7, and 271.3 ± 37.6 ms, respectively (p < 0.05 vs. baseline for all doses). At fast pacing frequencies, CPA significantly increased the magnitude of SR Ca2+ and APD alternans, most strongly at 10 μM (pacing cycle length = 220 ms: SR Ca2+ alternans magnitude: 57.1 ± 4.7 vs. 13.4 ± 8.9 AU; APD alternans magnitude 3.8 ± 1.9 vs. 0.2 ± 0.19 AU; p < 0.05 10 μM of CPA vs. baseline for both). SERCA inhibition also promoted the emergence of spatially discordant alternans. Notably, at all CPA doses, alternation of SR Ca2+ release occurred prior to alternation of diastolic SR Ca2+ load as pacing frequency increased. Simultaneous optical mapping of SR Ca2+ and Vm in the intact rabbit heart revealed that SERCA inhibition exacerbates pacing-induced SR Ca2+ and APD alternans magnitude, particularly at fast pacing frequencies. Importantly, SR Ca2+ release alternans always occurred before the onset of SR Ca2+ load alternans. These findings suggest that even in settings of diminished SERCA function, relative refractoriness of RyR Ca2+ release governs the onset of intracellular Ca2+ alternans.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2021) studied Cardiac alternans (n=10). Cyclopiazonic acid (CPA) vs. Baseline was evaluated on Sarcoplasmic reticulum Ca2+ reuptake time constant (tau) (p=<0.05). SERCA inhibition with 10 µM cyclopiazonic acid significantly prolonged SR Ca2+ reuptake time from 70.8 ms to 271.3 ms and exacerbated pacing-induced SR Ca2+ and APD alternans magnitude.
Synapse has enriched 10 related papers. Consider them for comparative context: